연구동향 분석
박사

Conservative management of patent ductus arteriosus in extremely low gestational age newborns : 초미숙아에서 동맥관 개존증의 보존적 치료 효과

성세인 2015년

논문상세정보
인용/피인용
' Conservative management of patent ductus arteriosus in extremely low gestational age newborns : 초미숙아에서 동맥관 개존증의 보존적 치료 효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • bronchopulmonary dysplasia
  • ductus arteriosus
  • patent ductus arteriosus
  • premature infant
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
33 0

0.0%

' Conservative management of patent ductus arteriosus in extremely low gestational age newborns : 초미숙아에서 동맥관 개존증의 보존적 치료 효과' 의 참고문헌

  • de Waal K, Evans N, van der Lee J, van Kaam A. Effect of lung recruitment on pulmonary, systemic, and ductal blood flow in preterm infants. The Journal of pediatrics. 2009;154:651-5.
  • Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, Van Hoestenberghe M-R, Theyskens C. Conservative treatment for patent ductus arteriosus in the preterm. Archives of disease in childhood Fetal and neonatal edition. 2007;92:F244-7.
  • Tauzin L, Joubert C, Noel A-C, Bouissou A, Moulies M-E. Effect of persistent patent ductus arteriosus on mortality and morbidity in very low-birthweight infants. Acta paediatrica (Oslo, Norway : 1992). 2012;101:419-23.
  • Sosenko IRS, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. The Journal of pediatrics. 2012;160:929-35.e1.
  • Saldeno YP, Favareto V, Mirpuri J. Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants. Journal of perinatology : official journal of the California Perinatal Association. 2012;32:953-8.
  • Rolland A, Shankar-Aguilera S, Diomande D, Zupan-Simunek V, Boileau P. Natural evolution of patent ductus arteriosus in the extremely preterm infant. Archives of disease in childhood Fetal and neonatal edition. 2014.
  • Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123:e138-44.
  • Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol. 2008;25(10):661-6.
  • Mirea L, Sankaran K, Seshia M, Ohlsson A, Allen AC, Aziz K, et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. The Journal of pediatrics. 2012;161:689-94.e1.
  • Kulkarni A, Richards J, Duffy D. Survey of management of patent ductus arteriosus in neonatal units across England. Archives of disease in childhood Fetal and neonatal edition. 2013;98:F465-6.
  • Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117:1113-21.
  • Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F99-104.
  • Kaempf JW, Wu YX, Kaempf aJ, Kaempf aM, Wang L, Grunkemeier G. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants? Journal of perinatology : official journal of the California Perinatal Association. 2012;32:344-8.
  • Johnston PG. Evidence-Based Use of Indomethacin and Ibuprofen in the Neonatal Intensive Care. Clinical Perinatology. 2012;39:111-36.
  • Jhaveri N, Moon-Grady A, Clyman RI. Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. The Journal of pediatrics. 2010;157:381-7, 7.e1.
  • Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of Patent Ductus Arteriosus With Oral Ibuprofen Suspension in Premature Newborns: A Pilot Study. Pediatrics. 2003;112:e354-e.
  • Fajardo MF, Claure N, Swaminathan S, Sattar S, Vasquez A, D'Ugard C, et al. Effect of positive end-expiratory pressure on ductal shunting and systemic blood flow in preterm infants with patent ductus arteriosus. Neonatology. 2014;105:9-13.
  • Dani C, Bertini G, Corsini I, Elia S, Vangi V, Pratesi S, et al. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance. Acta paediatrica (Oslo, Norway : 1992). 2008;97:1176-80.
  • Clyman RI. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Seminars in perinatology. 2013;37:102-7.
  • Chock VY. Predictors of Bronchopulmonary Dysplasia or Death in Premature Infants with a Patent Ductus Arteriosus. Pediatric Research. 2014;75:570-5.
  • Candel-Pau J, Sillo AL, Salinas FC, Redon EC, Menduina QF, Albert DC. Early versus Conventional Treatment for Patent Ductus Arteriosus in Preterm Infants. American journal of perinatology. 2013;30:289-96.
  • Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Archives of disease in childhood Fetal and neonatal edition. 2007;92:F498-502.
  • Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? Journal of perinatology : official journal of the California Perinatal Association. 2010;30:241-52.
  • Benitz WE. Patent ductus arteriosus: to treat or not to treat? Archives of disease in childhood Fetal and neonatal edition. 2012;97:F80-2.